F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

Avago Technologies Ltd Acquiring Broadcom Corp. The Deal may Put Qualcomm Under
Seven Year Long Lawsuit against Cephalon Settled with Teva Pharmaceuticals Payin
Exxon CEO Rebuffs Criticism of Not Doing Enough to Cut Carbon Emissions
McDonald’s Toasting Buns for Longer to get Better Taste
SWIFT says, Yuan is presently the Most-Used Currency in Asia for Payments to Chi
U.S. Dollar gets a Lift Strengthening Hopes of Raise in Interest Rate
Hackers Steal Tax Information of 100,000 American Taxpayers from IRS site
Charter Communications is Acquiring Time Warner Cable for about $56 Billion
Greece’s Interior Minister Says Greece will not be Able to Repay Debt Next Month
Nikos Voutsis, Greece’s Interior Minister
Rig Count in U.S Slows, Oil Trades Close to $60
Third Annual ‘March against Monsanto’ held on Saturday